Data as of Nov 21
| -0.04 / -2.31%|
The 3 analysts offering 12-month price forecasts for Oncothyreon Inc have a median target of 4.00, with a high estimate of 4.00 and a low estimate of 3.00. The median estimate represents a +136.69% increase from the last price of 1.69.
The current consensus among 4 polled investment analysts is to Buy stock in Oncothyreon Inc. This rating has held steady since November, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.